1. Home
  2. NYXH vs INGN Comparison

NYXH vs INGN Comparison

Compare NYXH & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.60

Market Cap

161.9M

Sector

Health Care

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.38

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYXH
INGN
Founded
2009
2001
Country
Belgium
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
177.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
NYXH
INGN
Price
$1.60
$6.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$9.33
$11.25
AVG Volume (30 Days)
217.1K
221.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
$213.98
$8.03
Revenue Next Year
$126.25
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$1.26
$5.34
52 Week High
$8.59
$9.13

Technical Indicators

Market Signals
Indicator
NYXH
INGN
Relative Strength Index (RSI) 35.60 45.63
Support Level $1.26 $6.00
Resistance Level $1.70 $6.72
Average True Range (ATR) 0.11 0.26
MACD 0.04 -0.03
Stochastic Oscillator 18.40 18.07

Price Performance

Historical Comparison
NYXH
INGN

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: